Muromonab-CD3 is a prescription drug licensed to treat transplant rejection following a liver, heart, or kidney transplant. It works by decreasing the activity of the immune system, so it will stop attacking the newly transplanted organ. Most people who receive this drug will experience some type of side effect, such as fever, diarrhea, or nausea.
What Is Muromonab-CD3?
Muromonab-CD3 (Orthoclone OKT®3) is a prescription medication approved to treat transplant rejection in people who have received a kidney, liver, or heart transplant. It is considered an immunosuppressant because it decreases the activity of the immune system.
Just like any medicine, muromonab-CD3 can cause side effects. As with many other immunosuppressant medications, the side effects can be significant. Although not everyone who receives this medicine will have problems, most people will experience some type of side effect during treatment.
Some of the common side effects of muromonab-CD3 include:
Food and Drug Administration Web site. Vaccines, Blood and Biologics, Resources for Healthcare Providers. Available at: http://www.fda.gov/BiologicsBloodVaccines/ResourcesforYou/HealthcareProviders/default.htm. Accessed September 30, 2011.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2008.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click